Ratings by Leerink
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/21/2026 | Asthika Goonewardene | Whitehawk Therapeutics | WHWK | New Coverage | Outperform (N/A) |
9.00 (N/A) |
3.79 (3.91) |
3.17% | Details |
| 7/21/2026 | Asthika Goonewardene | Molecular Partners | MOLN | New Coverage | Outperform (N/A) |
10.00 (N/A) |
4.00 (4.11) |
2.75% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 4,136 more... | |||||||||


